$345.00—Stale · unknown old
JPX • Last print unknown ago
$345.00—Stale · unknown old
Kokopelli Inc. specializes in application software solutions primarily for the healthcare sector, focusing on data analytics and patient management systems. The company operates predominantly in North America, leveraging its proprietary algorithms to enhance patient outcomes and streamline operational efficiencies for healthcare providers.
Kokopelli generates revenue primarily through subscription-based software licenses, which provide predictable cash flow. The company's competitive advantage lies in its advanced analytics capabilities, which offer healthcare providers actionable insights, improving patient care while reducing costs.
Adoption rates of digital health solutions in North America
Changes in healthcare regulations impacting software requirements
Partnerships with major healthcare providers
Customer retention rates and expansion within existing accounts
Technological disruption from emerging health tech startups
Regulatory changes affecting software compliance requirements
Increased competition from established players like Epic Systems and Cerner
Potential entry of tech giants into the healthcare software market
Negative operating margins indicating potential liquidity issues if revenue does not stabilize
Low free cash flow limiting investment in growth initiatives
moderate - The demand for healthcare software is somewhat insulated from economic cycles, but budget constraints during downturns can impact spending.
Interest rates affect Kokopelli's cost of capital and can influence healthcare spending; higher rates may lead to reduced investment in software solutions.
minimal - The company has low debt levels, which reduces its sensitivity to credit market fluctuations.
growth - Investors are likely attracted to Kokopelli for its potential in the expanding healthcare software market.
high - The stock has shown significant price volatility, particularly with a 1-year return of -50%.